Novo Nordisk A/S (NVO)
48.07
+0.43
(+0.90%)
USD |
NYSE |
Jun 26, 16:00
48.03
-0.04
(-0.08%)
After-Hours: 20:00
Novo Nordisk Free Cash Flow : 1.916B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.916B |
| December 31, 2025 | 4.403B |
| September 30, 2025 | 9.283B |
| June 30, 2025 | 9.066B |
| March 31, 2025 | 13.70B |
| December 31, 2024 | 10.21B |
| September 30, 2024 | 9.776B |
| June 30, 2024 | 9.572B |
| March 31, 2024 | 7.325B |
| December 31, 2023 | 10.16B |
| September 30, 2023 | 11.14B |
| June 30, 2023 | 9.475B |
| March 31, 2023 | 9.378B |
| December 31, 2022 | 9.060B |
| September 30, 2022 | 8.117B |
| June 30, 2022 | 8.541B |
| March 31, 2022 | 9.275B |
| December 31, 2021 | 7.568B |
| September 30, 2021 | 6.688B |
| June 30, 2021 | 5.337B |
| March 31, 2021 | 4.928B |
| December 31, 2020 | 4.571B |
| September 30, 2020 | 6.716B |
| June 30, 2020 | 7.042B |
| March 31, 2020 | 5.512B |
| Date | Value |
|---|---|
| December 31, 2019 | 5.332B |
| September 30, 2019 | 5.521B |
| June 30, 2019 | 4.734B |
| March 31, 2019 | 5.012B |
| December 31, 2018 | 5.101B |
| September 30, 2018 | 5.118B |
| June 30, 2018 | 5.454B |
| March 31, 2018 | 4.578B |
| December 31, 2017 | 4.935B |
| September 30, 2017 | 5.645B |
| June 30, 2017 | 5.834B |
| March 31, 2017 | 6.505B |
| December 31, 2016 | 5.954B |
| September 30, 2016 | 5.858B |
| June 30, 2016 | 5.639B |
| March 31, 2016 | 5.333B |
| December 31, 2015 | 4.892B |
| September 30, 2015 | 4.706B |
| June 30, 2015 | 5.053B |
| March 31, 2015 | 4.767B |
| December 31, 2014 | 4.868B |
| September 30, 2014 | 4.762B |
| June 30, 2014 | 3.687B |
| March 31, 2014 | 3.477B |
| December 31, 2013 | 3.969B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AstraZeneca PLC | 8.051B |
| GSK Plc | 5.741B |
| Johnson & Johnson | 17.80B |
| Eli Lilly & Co. | 10.37B |
| Merck & Co., Inc. | 14.12B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.665B |
| Cash from Investing (Quarterly) | -1.875B |
| Cash from Financing (Quarterly) | -2.583B |
| Free Cash Flow Per Share (Quarterly) | 0.4001 |
| Free Cash Flow to Equity (Quarterly) | -198.91M |
| Free Cash Flow to Firm (Quarterly) | 2.208B |
| Free Cash Flow Yield | 0.90% |